Cytokeratin 13 anticorps
(1 reference)-
- Antigène Voir toutes Cytokeratin 13 (KRT13) Anticorps
- Cytokeratin 13 (KRT13) (Keratin 13 (KRT13))
-
Reactivité
- Humain
-
Hôte
- Chèvre
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp Cytokeratin 13 est non-conjugé
-
Application
- Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Fonction
- Goat polyclonal antibody raised against synthetic peptide of KRT13.
- Séquence
- C-TSNASGRRTS DVRRP
- Réactivité croisée
- Humain
- Attributs du produit
- Antibody Reactive Against Synthetic Peptide.
- Immunogène
- A synthetic peptide corresponding to human KRT13.
- Top Product
- Discover our top product KRT13 Anticorps primaire
-
anti-Keratin 13 (KRT13) (N-Term) antibody
KRT13 Reactivité: Rat, Souris IHC, IF Hôte: Lapin Polyclonal unconjugated
anti-Keratin 13 (KRT13) (C-Term) antibodyKRT13 Reactivité: Rat, Souris IHC, IF Hôte: Lapin Polyclonal unconjugated
anti-Keratin 13 (KRT13) (AA 104-403) antibodyKRT13 Reactivité: Humain WB, IHC, ICC, IP Hôte: Lapin Polyclonal unconjugated
anti-Keratin 13 (KRT13) (AA 104-458) antibodyKRT13 Reactivité: Humain WB, IHC, ELISA, FACS Hôte: Souris Monoclonal 7D7B3 unconjugated
anti-Keratin 13 (KRT13) antibodyKRT13 Reactivité: Humain WB, IHC (p), IF, ICC, IHC (wm) Hôte: Lapin Polyclonal unconjugated
anti-Keratin 13 (KRT13) (AA 143-295) antibodyKRT13 Reactivité: Humain WB, ELISA, FACS Hôte: Souris Monoclonal 3G4 unconjugated
anti-Keratin 13 (KRT13) (AA 269-458) antibodyKRT13 Reactivité: Humain WB, IHC, IF Hôte: Lapin Polyclonal unconjugated
anti-Keratin 13 (KRT13) antibodyKRT13 Reactivité: Humain WB, IHC, IF Hôte: Lapin Monoclonal unconjugated
anti-Keratin 13 (KRT13) antibodyKRT13 Reactivité: Humain, Rat, Souris WB, IHC (p), IF (cc) Hôte: Lapin Monoclonal 5A3 unconjugated
anti-Keratin 13 (KRT13) antibodyKRT13 Reactivité: Humain IHC, IF, StM Hôte: Souris Monoclonal KRT13-2213 unconjugated
-
- Indications d'application
-
ELISA (1:128000)
Western Blot (0.1-0.3 μg/mL)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) (2-4 μg/mL)
The optimal working dilution should be determined by the end user. - Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 0.5 mg/mL
- Buffer
- In Tris saline, pH 7.3 (0.5 % BSA, 0.02 % sodium azide)
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
-
Store at -20°C.
Aliquot to avoid repeated freezing and thawing.
-
-
: "Kaposi's sarcoma-associated herpesvirus (KSHV) oncoprotein K13 bypasses TRAFs and directly interacts with the IkappaB kinase complex to selectively activate NF-kappaB without JNK activation." dans: The Journal of biological chemistry, Vol. 282, Issue 34, pp. 24858-65, (2007) (PubMed).
-
: "Kaposi's sarcoma-associated herpesvirus (KSHV) oncoprotein K13 bypasses TRAFs and directly interacts with the IkappaB kinase complex to selectively activate NF-kappaB without JNK activation." dans: The Journal of biological chemistry, Vol. 282, Issue 34, pp. 24858-65, (2007) (PubMed).
-
- Antigène
- Cytokeratin 13 (KRT13) (Keratin 13 (KRT13))
- Autre désignation
- Cytokeratin 13 (KRT13 Produits)
- Synonymes
- anticorps krt13, anticorps CK13, anticorps K13, anticorps Ka13, anticorps Krt-1.13, anticorps Krt1-13, anticorps ck13, anticorps k13, anticorps keratin 24, anticorps keratin 13, anticorps keratin 13, type I S homeolog, anticorps krt24, anticorps KRT13, anticorps Krt13, anticorps krt13.S, anticorps k13
- ID gène
- 3860
-
